{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:33:44Z","timestamp":1792301624164,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/wnf.0b013e3181bf1dbe","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T06:52:01Z","timestamp":1267080721000},"page":"35-39","source":"Crossref","is-referenced-by-count":55,"title":["Pregabalin in the Treatment of Chronic Migraine"],"prefix":"10.1097","volume":"33","author":[{"given":"Elena P.","family":"Calandre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Garcia-Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rico-Villademoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S.","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen M.","family":"Rodriguez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1526-4610.2007.00647.x","article-title":"Chronic daily headache in a primary care population: prevalence and headache impact test scores.","volume":"47","author":"Coeytaux","year":"2007","journal-title":"Headache"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1526-4610.1999.3903190.x","article-title":"Epidemiology of chronic daily headache in the general population.","volume":"39","author":"Castillo","year":"1999","journal-title":"Headache"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/s0304-3959(02)00348-2","article-title":"Prevalence and description of chronic daily headache in the general population in France.","volume":"102","author":"Lanteri-Minet","year":"2003","journal-title":"Pain"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.47.4.871","article-title":"Classification of daily and near-daily headaches: field trial of revised IHS criteria.","volume":"47","author":"Silberstein","year":"1996","journal-title":"Neurology"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1468-2982.1999.1910847.x","article-title":"Transformed migraine: a proposal for the modification of its diagnostic criteria.","volume":"19","author":"Guitera","year":"1999","journal-title":"Cephalalgia"},{"issue":"suppl 1","key":"R6-9-20210203","first-page":"9","article-title":"The international classification of headache disorders: 2nd edition.","volume":"24","year":"2004","journal-title":"Cephalalgia"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","article-title":"New appendix criteria open for a broader concept of chronic migraine.","volume":"26","author":"Headache Classification Committee; Olesen","year":"2006","journal-title":"Cephalalgia"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1526-4610.2000.00014.x","article-title":"Prophylactic pharmacological treatment of chronic daily headache.","volume":"40","author":"Redillas","year":"2000","journal-title":"Headache"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10194-006-0339-6","article-title":"Chronic migraine prevention with topiramate.","volume":"7","author":"Peres","year":"2006","journal-title":"J Headache Pain"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1526-4610.2008.01185.x","article-title":"Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.","volume":"48","author":"Silberstein","year":"2008","journal-title":"Headache"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1526-4610.2005.05073a.x","article-title":"Botox therapy for refractory chronic migraine.","volume":"45","author":"Conway","year":"2005","journal-title":"Headache"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1590\/S0004-282X2007000400009","article-title":"Botulinum toxin type A in refractory chronic migraine: an open-label trial.","volume":"65","author":"Menezes","year":"2007","journal-title":"Arq Neuropsiquiatr"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1526-4610.2007.00963.x","article-title":"Botulinum toxin type A in the treatment of chronic migraine without medication overuse.","volume":"48","author":"Freitag","year":"2008","journal-title":"Headache"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.wnf.0000192136.46145.44","article-title":"Efficacy of topiramate and valproate in chronic migraine.","volume":"28","author":"Bartolini","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"449","DOI":"10.33588\/rn.4709.2008503","article-title":"Tratamiento preventivo de la migrana cronica con zonisamida: un estudio en pacientes refractarios o intolerantes a topiramato.","volume":"47","author":"Pascual-Gomez","year":"2008","journal-title":"Rev Neurol"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1213\/01.ane.0000287643.13410.5e","article-title":"Pregabalin: its pharmacology and use in pain management.","volume":"105","author":"Gajraj","year":"2007","journal-title":"Anesth Analg"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3959(00)00478-4","article-title":"Deconstructing migraine headache into peripheral and central sensitization.","volume":"89","author":"Burstein","year":"2001","journal-title":"Pain"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1468-2982.1995.015002132.x","article-title":"Platelet and plasma levels of glutamate and glutamine in migraine with and without aura.","volume":"15","author":"Cananzi","year":"1995","journal-title":"Cephalalgia"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1468-2982.2004.00750.x","article-title":"Cerebrospinal fluid glutamate levels in chronic migraine.","volume":"24","author":"Peres","year":"2004","journal-title":"Cephalalgia"},{"key":"R20-9-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1468-2982.2008.01749.x","article-title":"Effective prophylactic treatments of migraine lower plasma glutamate levels.","volume":"29","author":"Ferrari","year":"2009","journal-title":"Cephalalgia"},{"key":"R21-9-20210203","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1468-2982.2006.01153.x","article-title":"Pregabalin in the therapy of hypnic headache.","volume":"26","author":"Ulrich","year":"2006","journal-title":"Cephalalgia"},{"key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/WNF.0b013e31814a62e1","article-title":"Remission of migraine attacks in a patient with depression who is taking pregabalin.","volume":"31","author":"Masdrakis","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1468-2982.2003.00592.x","article-title":"Topiramate in the treatment of chronic migraine.","volume":"23","author":"Silvestrini","year":"2003","journal-title":"Cephalalgia"},{"key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"TOPMAT -MIG-201 (TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"R26-9-20210203","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1526-4610.2003.03106.x","article-title":"Factors associated with burden of primary headache in a specialty clinic.","volume":"43","author":"Cassidy","year":"2003","journal-title":"Headache"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-201001000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T21:49:50Z","timestamp":1739915390000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201001000-00009"}},"subtitle":["An Open-Label Study"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181bf1dbe","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}